Vaccines to Achieve Affordable Universal Coverage
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 86
Special Issue Editor
Special Issue Information
Dear Colleagues,
Adopted by all United Nations members, the 17 Sustainable Development Goals (SDGs) aim to ensure universal access to health and promote well-being, but they face challenges such as disparities in access, vaccine literacy, and misinformation, which impact other SDGs. We invite contributions to a Special Issue dedicated to vaccines’ pivotal role in achieving the SDGs. This Special Issue aims to foster diverse discussions across various disciplines, highlighting vaccines’ multidimensional impact on global health and development. We welcome research contributions based on the role of vaccines in achieving the SDGs, challenges related to vaccines and the SDGs, international stakeholders’ involvement in vaccination, the socioeconomic impact of vaccines, and vaccine literacy.
We invite research contributions that address, but are not limited to, the following areas:
- Role of vaccines for SDGs;
- Existing and emerging challenges associated with vaccines for SDGs;
- Evaluation of international stakeholders of vaccination for SDGs;
- Socioeconomic impact of vaccines for SDGs;
- Vaccination literacy for SDGs;
- Innovations in vaccine developments for SDGs.
Prof. Pui Hong Chung
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Sustainable Development Goals (SDGs)
- global health
- vaccines
- vaccine equity
- vaccine disparities
- vaccine accessibility
- vaccination literacy
- vaccine innovation
- disease prevention
- vaccine policy and implementation
- public health policy
- health economics
- healthcare disparities
- universal health coverage
- international health partnerships
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
